ShiftPixy, Inc.

2023 Q4 Form 10-K Financial Statement

#000147793223009152 Filed on December 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2023

Balance Sheet

Concept 2023 Q4 2023 Q3 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.493M $75.00K $75.00K
YoY Change -98.74% -99.94% -99.94%
Cash & Equivalents $1.493M $75.00K $75.00K
Short-Term Investments
Other Short-Term Assets $532.0K $532.0K $1.371M
YoY Change 84.72% 184.49% 55.27%
Inventory
Prepaid Expenses $636.0K $839.0K
Receivables $2.073M $590.0K $2.374M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $4.734M $3.820M $3.820M
YoY Change -96.13% -96.84% -96.84%
LONG-TERM ASSETS
Property, Plant & Equipment $1.469M $1.622M $2.488M
YoY Change -51.36% -41.42% -63.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $192.0K $192.0K $192.0K
YoY Change -79.13% -79.11% -79.11%
Total Long-Term Assets $2.440M $2.680M $2.680M
YoY Change -69.13% -65.48% -65.48%
TOTAL ASSETS
Total Short-Term Assets $4.734M $3.820M $3.820M
Total Long-Term Assets $2.440M $2.680M $2.680M
Total Assets $7.174M $6.500M $6.500M
YoY Change -94.49% -94.95% -94.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.47M $6.500M $16.69M
YoY Change 48.26% -62.04% -2.51%
Accrued Expenses $35.63M $3.900M $33.75M
YoY Change 84.24% -76.54% 103.07%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $59.10M $54.84M $54.84M
YoY Change -61.72% -63.94% -63.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.558M $2.790M $2.790M
YoY Change -68.2% -65.29% -65.29%
Total Long-Term Liabilities $2.558M $2.790M $2.790M
YoY Change -68.2% -65.29% -65.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $59.10M $54.84M $54.84M
Total Long-Term Liabilities $2.558M $2.790M $2.790M
Total Liabilities $61.66M $57.63M $57.63M
YoY Change -62.04% -64.01% -66.02%
SHAREHOLDERS EQUITY
Retained Earnings -$231.9M -$226.4M
YoY Change 17.06% 17.46%
Common Stock $0.00 $0.00
YoY Change -100.0% -100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$54.48M -$51.13M -$51.13M
YoY Change
Total Liabilities & Shareholders Equity $7.174M $6.500M $6.500M
YoY Change -94.49% -94.95% -94.95%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2023

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023 pixy Liquidity Capital Resources And Going Concernpolicytextblock
LiquidityCapitalResourcesAndGoingConcernpolicytextblock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of August 31, 2023, the Company had cash of $0.1 million and a working capital deficit of $50.1 million. During the year ended August 31, 2023, the Company used approximately $9.2 million of cash from its continuing operations and incurred recurring losses, resulting in an accumulated deficit of $226.4 million. As of August 31, 2023, the Company is delinquent with respect to remitting payroll tax payments to the IRS, states and local jurisdictions. The Company has retained tax counsel and has been in near constant communication with the IRS regarding processing its Employee Retention Tax Credits (“ERTCs”).  On September 14, 2023, the IRS has a moratorium on processing new ERTC claims and many of the Company’s clients are seeking refunds. Recently, the Company has filed ERTC claims for our clients and has not received any acceptance from the IRS. Some clients have filed suits against the Company, demanding that the Company take action to file for additional ERTCs for certain tax periods.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">ShiftPixy have received notices from the IRS that they owe approximately $11.8 million for unpaid tax liabilities, including penalties and interest. The balances reported on such notices do not represent the full payroll tax liability of ShiftPixy as of August 31, 2023. ShiftPixy expects its payroll tax liabilities, penalties and interest to increase in the future. Moreover, the IRS has threatened to take enforced collection against ShiftPixy, Inc. and ShiftPixy, potentially in addition to other subsidiaries.  ShiftPixy have taken steps to preserve so-called “collection due process rights” and present collection alternatives to the proposed enforced collection.  Specifically: </p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="width:1%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">ShiftPixy had a collection due process hearing with the IRS Independent Office of Appeals on October 24, 2023. On October 24 and November 6, 2023, ShiftPixy requested that the IRS Independent Office of Appeals (“Appeals”), among other things, abate additions to tax and related interest for the failure to make required deposits and the failure to timely pay required tax. That request is pending before Appeals; and</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="width:1%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 27, 2023, the IRS issued to ShiftPixy a Letter 1058, <em>Final Notice, Notice of Intent to Levy and Notice of Your Right to a Hearing</em>, with respect to ShiftPixy's (a) Form 941 liabilities for the tax periods ending March 31, June 30, September 30, and December 31, 2022, and (b) Form 940 liabilities for the tax period ending December 31, 2022 (such liabilities, “ShiftPixy’s Liability That Are Subject to Enforced Collection”). On November 26, 2023, ShiftPixy timely filed a Form 12153, <em>Request for a Collection Due Process or Equivalent Hearing</em>, with respect to ShiftPixy's Liability That Are Subject to Enforced Collection. That Form 12153 requested, among other things, an abatement of additions to tax and related interest for the failure to make required deposits and the failure to timely pay required tax that are included within ShiftPixy Corporate Services’ Liability That Are Subject to Enforced Collection. That request is pending before the IRS Independent Office of Appeals.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">    </p><p style="font-size:10pt;font-family:times new roman;margin:0px">Notwithstanding the above-described requests for a collection due process hearing, should the IRS determine the collectability of tax be in jeopardy, the IRS can, with limited notice, levy the affected Company’s bank accounts and subject it to enforced collection if ShiftPixy cannot obtain a resolution of the payroll tax issues, the United States Tax Court can (and will be asked to) review Appeals’ determination. There is no assurance that the IRS will abate penalties and interest currently assessed against ShiftPixy. If ShiftPixy gets abated the outstanding penalties, and interest or raise the necessary capital to fund its payroll tax obligations and collection alternative, it may cause ShiftPixy to file for bankruptcy protection in the near future.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has taken aggressive steps to reduce its overhead expenses. The Company’s plans and expectations for the next twelve months include raising additional capital which may help fund the Company’s operations and seeking acquisitions targets funded by debt or stock by Company’s in staffing services as the key driver towards its success.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company expects to engage in additional sales of its securities during Fiscal 2024, either through registered public offerings or private placements, the proceeds of which the Company intends to use to fund its operations. If these sources do not provide the capital necessary to fund the Company’s operations during the next twelve months, it may need to curtail certain aspects of its operations or expansion activities, consider the sale of additional assets at distressed prices, or consider other means of financing. The Company is also seeking acquisition targets funded by debt and stock, for growth, a recurring revenue base, significant gross profit conversion, margin expansion opportunities, a light industrial sector focus, a blue-chip client base, cyclical tailwinds, and a tenured management team willing and able to execute a comprehensive integration plan. The Company can give no assurance that it will be successful in implementing its business plan and obtaining financing on advantageous terms, or that any such additional financing will be available. These Consolidated Financial Statements do not include any adjustments for this uncertainty.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Under the existing accounting guidance, management must evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the Consolidated Financial Statements are issued. This evaluation initially does not take into consideration the potential mitigating effect of management’s plans that have not been fully implemented as of the date the Consolidated Financial Statements are issued. When substantial doubt is determined to exist, management evaluates whether the mitigating effect of its plans sufficiently alleviates substantial doubt about the Company’s ability to continue as a going concern. The mitigating effect of management’s plans; however, is only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date the  Consolidated Financial Statements are issued, and (2) it is probable that the plans, when implemented, may mitigate the relevant conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date the consolidated financial statements are issued. Therefore, management has concluded that there is substantial doubt about the Company’s ability to continue as a going concern for the next twelve months from the date of the issuance of the financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Historically, the Company’s principal source of financing has come through the sale of the Company’s common stock, including in certain instances, warrants and the issuance of convertible notes.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 5, 2023, the Company, entered into a securities purchase agreement with an institutional investor, pursuant to which the Company agreed to issue and sell to the investor (i) in a registered direct offering, 56,250 shares at a  price of $26.40 per share, and pre-funded warrants, to purchase up to 38,125 shares of common Stock at a price of $26.40 per share and an exercise price of $0.0001 per share of common stock, and (ii) in a concurrent securities private placement, common stock purchase warrants (the “Private Placement Warrants”), exercisable for an aggregate of up to 56,250 shares of common stock, at an exercise price of $26.40 per share of common stock. The pre-funded warrants were exercised in October 2023 and the Company issued 38,125 shares of common stock. The net proceeds of this offering were $2.0 million. </p>
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
139934 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22272 shares
CY2022 pixy Financing Receivable Excluding Accrued Interests Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestsCreditLossExpenseReversal
4000000 usd
CY2023Q3 pixy Disposal Group Including Discontinued Operation Workers Compensation Asset Current
DisposalGroupIncludingDiscontinuedOperationWorkersCompensationAssetCurrent
0 usd
CY2022Q3 pixy Disposal Group Including Discontinued Operation Workers Compensation Asset Current
DisposalGroupIncludingDiscontinuedOperationWorkersCompensationAssetCurrent
0 usd
CY2022Q3 pixy Disposal Group Including Discontinued Operation Workers Compensation Asset Noncurrent
DisposalGroupIncludingDiscontinuedOperationWorkersCompensationAssetNoncurrent
0 usd
CY2023Q3 pixy Disposal Group Including Discontinued Operation Workers Compensation Asset Noncurrent
DisposalGroupIncludingDiscontinuedOperationWorkersCompensationAssetNoncurrent
0 usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
116700000 usd
CY2021Q2 pixy Other Commitments Percentage Of Outstanding Shares Per Acquisition Company
OtherCommitmentsPercentageOfOutstandingSharesPerAcquisitionCompany
0.15 pure
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
270032328 shares
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001675634
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--08-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
0 shares
CY2023Q3 us-gaap Financial Instrument Subject To Mandatory Redemption Par Value Per Share
FinancialInstrumentSubjectToMandatoryRedemptionParValuePerShare
0
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
358333 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
507383 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21390 shares
CY2022 pixy Weighted Average Number Of Shares Of Common Stock Outstanding Loss Per Share
WeightedAverageNumberOfSharesOfCommonStockOutstandingLossPerShare
358333 shares
CY2022Q3 us-gaap Other Liabilities
OtherLiabilities
1300000.0 usd
CY2022Q3 pixy Liability Before Settlement Against Everest Program
LiabilityBeforeSettlementAgainstEverestProgram
1400000.0 usd
CY2022Q3 us-gaap Assets Net
AssetsNet
2769000 usd
CY2022Q3 pixy Accumulated Depreciation Amortization
AccumulatedDepreciationAmortization
-1255000 usd
CY2023 us-gaap Longterm Purchase Commitment Period
LongtermPurchaseCommitmentPeriod
P5Y
CY2023Q3 pixy Unpaid Tax Liabilities
UnpaidTaxLiabilities
11800000.0 usd
CY2022 pixy Weighted Remaining Life Years Exercisable
WeightedRemainingLifeYearsExercisable
P7Y2M12D
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4673321 usd
CY2023Q3 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
3586752 shares
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
200000 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
700000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
300000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1100000 usd
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
13.20
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
35.68
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
358333 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1750 shares
CY2021Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0001
CY2021Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
12000000.0 usd
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
315
CY2022 us-gaap Officers Compensation
OfficersCompensation
0 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
200000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1100000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2022Q3 pixy Contingent Liability
ContingentLiability
3800000.0 usd
CY2023 pixy Operating Leases Impairment Loss
OperatingLeasesImpairmentLoss
100000.0 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
37978000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3900000.0 usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-08-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
024-10557
CY2023 dei Entity Registrant Name
EntityRegistrantName
SHIFTPIXY, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-4211438
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
4101 NW 25th Street
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Miami
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33131
CY2023 dei City Area Code
CityAreaCode
888
CY2023 dei Local Phone Number
LocalPhoneNumber
798-9100
CY2023 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Trading Symbol
TradingSymbol
PIXY
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Public Float
EntityPublicFloat
7000000.0 usd
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5397698 shares
CY2023 dei Auditor Name
AuditorName
Marcum LLP
CY2023 dei Auditor Location
AuditorLocation
New York, NY
CY2023 dei Auditor Firm
AuditorFirmId
688
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
618000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
590000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
279000 usd
CY2023Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
1784000 usd
CY2022Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
2105000 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
839000 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
696000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
532000 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
187000 usd
CY2023Q3 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
0 usd
CY2022Q3 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
116969000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
3820000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
120854000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1622000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2769000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
866000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4076000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
192000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
919000 usd
CY2023Q3 us-gaap Assets
Assets
6500000 usd
CY2022Q3 us-gaap Assets
Assets
128618000 usd
CY2023Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
16692000 usd
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
16225000 usd
CY2023Q3 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
29595000 usd
CY2022Q3 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
14175000 usd
CY2023Q3 pixy Payroll Related Liabilities
PayrollRelatedLiabilities
2940000 usd
CY2022Q3 pixy Payroll Related Liabilities
PayrollRelatedLiabilities
2777000 usd
CY2023Q3 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
1219000 usd
CY2022Q3 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
567000 usd
CY2023Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
4389000 usd
CY2022Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1362000 usd
CY2022Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
11500000 shares
CY2022Q3 us-gaap Financial Instrument Subject To Mandatory Redemption Par Value Per Share
FinancialInstrumentSubjectToMandatoryRedemptionParValuePerShare
10.15
CY2023Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Current
SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent
0 usd
CY2022Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Current
SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent
116969000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
54835000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
152075000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2790000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3541000 usd
CY2023Q3 pixy Accrued Workers Compensation Costs Liability Noncurrent
AccruedWorkersCompensationCostsLiabilityNoncurrent
-0 usd
CY2022Q3 pixy Accrued Workers Compensation Costs Liability Noncurrent
AccruedWorkersCompensationCostsLiabilityNoncurrent
1227000 usd
CY2023Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
0 usd
CY2022Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
3269000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
57625000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
160112000 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
358333 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
507383 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21390 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
175226000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
151737000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-226351000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-192725000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-51125000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-40988000 usd
CY2023Q3 us-gaap Minority Interest
MinorityInterest
0 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
9494000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-51125000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-31494000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6500000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
128618000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17129000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36002000 usd
CY2023 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
16251000 usd
CY2022 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
34227000 usd
CY2023 us-gaap Gross Profit
GrossProfit
878000 usd
CY2022 us-gaap Gross Profit
GrossProfit
1775000 usd
CY2023 us-gaap Salaries And Wages
SalariesAndWages
15762000 usd
CY2022 us-gaap Salaries And Wages
SalariesAndWages
14821000 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
3609000 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
7673000 usd
CY2023 pixy Software Development
SoftwareDevelopment
263000 usd
CY2022 pixy Software Development
SoftwareDevelopment
2529000 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
523000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
509000 usd
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1435000 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
2497000 usd
CY2022 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
3851000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10746000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15636000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
34835000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
45019000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-33957000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-43244000 usd
CY2023 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
515000 usd
CY2023 us-gaap Other Income
OtherIncome
642000 usd
CY2022 us-gaap Other Income
OtherIncome
316000 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
642000 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
199000 usd
CY2023 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-33315000 usd
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-43443000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-38000 usd
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-33328000 usd
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-43405000 usd
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
242000 usd
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-590000 usd
CY2023 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
-540000 usd
CY2022 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 usd
CY2023 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-33626000 usd
CY2022 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-43995000 usd
CY2023 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
127145000 usd
CY2022 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 usd
CY2023 us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount1
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1
0 usd
CY2022 us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount1
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1
-15703000 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-160771000 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-59698000 usd
CY2023 pixy Continuing Operations Basic And Diluted
ContinuingOperationsBasicAndDiluted
-299.27
CY2022 pixy Continuing Operations Basic And Diluted
ContinuingOperationsBasicAndDiluted
-3523.58
CY2023 pixy Discontinued Operations Basic And Diluted
DiscontinuedOperationsBasicAndDiluted
0.45
CY2022 pixy Discontinued Operations Basic And Diluted
DiscontinuedOperationsBasicAndDiluted
-35.17
CY2023 pixy Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-298.823
CY2022 pixy Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-3558.75
CY2023 pixy Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
538017 shares
CY2022 pixy Weighted Average Common Shares Outstanding Basic And Diluted
WeightedAverageCommonSharesOutstandingBasicAndDiluted
16775 shares
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40923000 usd
CY2022 pixy Asc842 Adoption Catch Up Adjustment
Asc842AdoptionCatchUpAdjustment
608000 usd
CY2022 pixy Common Stock Issued For Private Placement Net Of Offering Costs Amount
CommonStockIssuedForPrivatePlacementNetOfOfferingCostsAmount
4183000 usd
CY2022 pixy Common Stock Issued On Exercised Warrants Net Of Offering Cost1 Amount
CommonStockIssuedOnExercisedWarrantsNetOfOfferingCost1Amount
5409000 usd
CY2022 pixy Common Stock Issued On Exercised Warrants Net Of Offering Costs2 Amount
CommonStockIssuedOnExercisedWarrantsNetOfOfferingCosts2Amount
1163000 usd
CY2022 pixy Prefunded Warrants For Private Placement Net Of Offering Cost
PrefundedWarrantsForPrivatePlacementNetOfOfferingCost
6861000 usd
CY2022 pixy Stock Based Compensation Expense
StockBasedCompensationExpense
1286000 usd
CY2022 pixy Remeasurement Of Ihc Temporary Equity
RemeasurementOfIhcTemporaryEquity
-13675000 usd
CY2022 pixy Preferred Stock Series A Issued Amount
PreferredStockSeriesAIssuedAmount
3721000 usd
CY2022 pixy Common Stock Issued For Preferred Stock Series A Conversion Amount
CommonStockIssuedForPreferredStockSeriesAConversionAmount
0 usd
CY2022 pixy Cancellation Of Non Controlling On Withdrawal Of Spacs S1 Registration Statements
CancellationOfNonControllingOnWithdrawalOfSpacsS1RegistrationStatements
-37978000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-43995000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-31494000 usd
CY2023 pixy Fair Market Value Increase Of Preferred Stock Series A Prior To Reverse Stock Split
FairMarketValueIncreaseOfPreferredStockSeriesAPriorToReverseStockSplit
127145000 usd
CY2023 pixy Preferential Dividend Of Preferred Series A Stock
PreferentialDividendOfPreferredSeriesAStock
-127145000 usd
CY2023 pixy Common Stock Issued On Exercised Prefunded Warrants Amount
CommonStockIssuedOnExercisedPrefundedWarrantsAmount
1000 usd
CY2023 pixy Common Stock Issued For Private Placement Net Of Offering Cost Amount
CommonStockIssuedForPrivatePlacementNetOfOfferingCostAmount
4387000 usd
CY2023 pixy Common Stock Issued For Private Placement Net Of Offering Costs Amount
CommonStockIssuedForPrivatePlacementNetOfOfferingCostsAmount
2685000 usd
CY2023 pixy Common Stock Issued On Conversion Of Preferred Stock Series A Amount
CommonStockIssuedOnConversionOfPreferredStockSeriesAAmount
0 usd
CY2023 pixy Stock Based Compensation Expense
StockBasedCompensationExpense
954000 usd
CY2023 pixy Warrant Modification Expense
WarrantModificationExpense
324000 usd
CY2023 pixy Additional Shares Issue Due To Reverse Stock Split Amount
AdditionalSharesIssueDueToReverseStockSplitAmount
0 usd
CY2023 pixy Net Proceeds Of Atm Net Of Offering Expenses Amount
NetProceedsOfAtmNetOfOfferingExpensesAmount
1973000 usd
CY2023 pixy Stock Based Compensation Conditional Option Preferred Series A Grant
StockBasedCompensationConditionalOptionPreferredSeriesAGrant
3131000 usd
CY2023 pixy Deconsolidation Of Vie
DeconsolidationOfVie
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-33086000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-51125000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-33626000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-43995000 usd
CY2023 pixy Income Loss From Discontinued Operation Net Of Tax
IncomeLossFromDiscontinuedOperationNetOfTax
242000 usd
CY2022 pixy Income Loss From Discontinued Operation Net Of Tax
IncomeLossFromDiscontinuedOperationNetOfTax
-590000 usd
CY2023 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
-540000 usd
CY2022 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 usd
CY2023 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-33328000 usd
CY2022 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-43405000 usd
CY2023 us-gaap Interest And Debt Expense
InterestAndDebtExpense
187000 usd
CY2022 us-gaap Interest And Debt Expense
InterestAndDebtExpense
0 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
523000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
509000 usd
CY2023 pixy Impaired Asset Charge
ImpairedAssetCharge
1435000 usd
CY2022 pixy Impaired Asset Charge
ImpairedAssetCharge
0 usd
CY2023 pixy Purchase Price Note Receivable Reserve
PurchasePriceNoteReceivableReserve
0 usd
CY2022 pixy Purchase Price Note Receivable Reserve
PurchasePriceNoteReceivableReserve
4004000 usd
CY2023 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
2497000 usd
CY2022 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
3851000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
954000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1283000 usd
CY2023 pixy Share Based Payment Arrangement Noncash Expense Directors
ShareBasedPaymentArrangementNoncashExpenseDirectors
150000 usd
CY2022 pixy Share Based Payment Arrangement Noncash Expense Directors
ShareBasedPaymentArrangementNoncashExpenseDirectors
0 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
3131000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
0 usd
CY2023 pixy Warrant Modification Noncash Expense
WarrantModificationNoncashExpense
324000 usd
CY2022 pixy Warrant Modification Noncash Expense
WarrantModificationNoncashExpense
0 usd
CY2023 pixy Expensed Spac Offering Costs
ExpensedSPACOfferingCosts
0 usd
CY2022 pixy Expensed Spac Offering Costs
ExpensedSPACOfferingCosts
515000 usd
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
713000 usd
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
382000 usd
CY2023 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-1040000 usd
CY2022 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-498000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
219000 usd
CY2023 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
321000 usd
CY2022 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
636000 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-488000 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-152000 usd
CY2023 pixy Deposits Workers Compensation
DepositsWorkersCompensation
0 usd
CY2022 pixy Deposits Workers Compensation
DepositsWorkersCompensation
541000 usd
CY2023 pixy Increase Decrease In Deposits And Other Assets
IncreaseDecreaseInDepositsAndOtherAssets
0 usd
CY2022 pixy Increase Decrease In Deposits And Other Assets
IncreaseDecreaseInDepositsAndOtherAssets
25000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
459000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6409000 usd
CY2023 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
15420000 usd
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
4091000 usd
CY2023 pixy Increase Decrease In Payroll Related Liabilities
IncreaseDecreaseInPayrollRelatedLiabilities
163000 usd
CY2022 pixy Increase Decrease In Payroll Related Liabilities
IncreaseDecreaseInPayrollRelatedLiabilities
4088000 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
631000 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
CY2023 pixy Increase Decrease In Accrued Workers Compensation
IncreaseDecreaseInAccruedWorkersCompensation
465000 usd
CY2022 pixy Increase Decrease In Accrued Workers Compensation
IncreaseDecreaseInAccruedWorkersCompensation
-515000 usd
CY2023 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
24085000 usd
CY2022 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
25886000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-9243000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-17519000 usd
CY2023 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0 usd
CY2022 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-1000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9243000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17520000 usd
CY2023 pixy Payments For Investment Of Initial Public Offering Proceeds
PaymentsForInvestmentOfInitialPublicOfferingProceeds
0 usd
CY2022 pixy Payments For Investment Of Initial Public Offering Proceeds
PaymentsForInvestmentOfInitialPublicOfferingProceeds
-116969000 usd
CY2023 pixy Redeemable Noncontrolling Interest Equity Common Redemption Funds Distributed To Shareholders
RedeemableNoncontrollingInterestEquityCommonRedemptionFundsDistributedToShareholders
117574000 usd
CY2022 pixy Redeemable Noncontrolling Interest Equity Common Redemption Funds Distributed To Shareholders
RedeemableNoncontrollingInterestEquityCommonRedemptionFundsDistributedToShareholders
0 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
117228000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-117463000 usd
CY2023 pixy Proceeds From Variable Interest Entity Initial Public Offering
ProceedsFromVariableInterestEntityInitialPublicOffering
0 usd
CY2022 pixy Proceeds From Variable Interest Entity Initial Public Offering
ProceedsFromVariableInterestEntityInitialPublicOffering
116725000 usd
CY2023 pixy Payments To Variable Interest Entity Shareholders
PaymentsToVariableInterestEntityShareholders
117574000 usd
CY2022 pixy Payments To Variable Interest Entity Shareholders
PaymentsToVariableInterestEntityShareholders
0 usd
CY2023 pixy Spac Related Offering Costs Paid
SpacRelatedOfferingCostsPaid
0 usd
CY2022 pixy Spac Related Offering Costs Paid
SpacRelatedOfferingCostsPaid
-3663000 usd
CY2023 pixy Proceeds From Issuance Of Private Placement Net Of Offering Costs
ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts
7072000 usd
CY2022 pixy Proceeds From Issuance Of Private Placement Net Of Offering Costs
ProceedsFromIssuanceOfPrivatePlacementNetOfOfferingCosts
4183000 usd
CY2023 pixy Proceeds From At The Market Offering Net Of Offering Costs
ProceedsFromAtTheMarketOfferingNetOfOfferingCosts
1973000 usd
CY2022 pixy Proceeds From At The Market Offering Net Of Offering Costs
ProceedsFromAtTheMarketOfferingNetOfOfferingCosts
0 usd
CY2023 pixy Proceeds From Private Placement Prefunded Warrants Net Of Offering Costs
ProceedsFromPrivatePlacementPrefundedWarrantsNetOfOfferingCosts
1000 usd
CY2022 pixy Proceeds From Private Placement Prefunded Warrants Net Of Offering Costs
ProceedsFromPrivatePlacementPrefundedWarrantsNetOfOfferingCosts
6861000 usd
CY2023 pixy Proceeds From Exercised Warrants Net Of Offering Costs
ProceedsFromExercisedWarrantsNetOfOfferingCosts
0 usd
CY2022 pixy Proceeds From Exercised Warrants Net Of Offering Costs
ProceedsFromExercisedWarrantsNetOfOfferingCosts
6573000 usd
CY2023 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 usd
CY2022 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
3723000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-108528000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
134402000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-543000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-581000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
618000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1199000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
618000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
175000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
1000 usd
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
31000 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
4000 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
801000 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2023 pixy Deconsolidation Of Variable Interest Entity
DeconsolidationOfVariableInterestEntity
9494000 usd
CY2022 pixy Deconsolidation Of Variable Interest Entity
DeconsolidationOfVariableInterestEntity
0 usd
CY2023 pixy Transfer Of Preferred Shares To Common Shares
TransferOfPreferredSharesToCommonShares
1000 usd
CY2022 pixy Transfer Of Preferred Shares To Common Shares
TransferOfPreferredSharesToCommonShares
0 usd
CY2023 pixy Remeasurement Of Class A Ordinary Shares Subject To Redemption
RemeasurementOfClassAOrdinarySharesSubjectToRedemption
0 usd
CY2022 pixy Remeasurement Of Class A Ordinary Shares Subject To Redemption
RemeasurementOfClassAOrdinarySharesSubjectToRedemption
244000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Continuation as a going concern; management assumes that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets and liquidation of all liabilities in the normal course of business</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:'times new roman'">Liability for legal contingencies</span></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-JUSTIFY: inter-ideograph; MARGIN: 0px; text-align:justify;"><span style="font-family:'times new roman'">Projected development of workers’ compensation claims</span></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-JUSTIFY: inter-ideograph; MARGIN: 0px; text-align:justify;"><span style="font-family:'times new roman'">Payroll tax and associated penalties and interest</span></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Impairment of long-lived assets</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions that are difficult to measure of value.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Management regularly reviews the key factors and assumptions to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience, and reasonable assumptions. After such valuation, if deemed appropriate, those estimates are adjusted accordingly.</p>
CY2023Q3 us-gaap Cash
Cash
100000 usd
CY2023Q3 pixy Working Capital Deficit
WorkingCapitalDeficit
50100000 usd
CY2023 pixy Net Cash Provided By Used In Operating Activities Continuing Operation
NetCashProvidedByUsedInOperatingActivitiesContinuingOperation
-9200000 usd
CY2023Q3 pixy Retained Earning Accumulated Deficit
RetainedEarningAccumulatedDeficit
226400000 usd
CY2023Q3 pixy Unbilled Contract Receivable
UnbilledContractReceivable
1800000 usd
CY2022Q3 pixy Unbilled Contract Receivable
UnbilledContractReceivable
2100000 usd
CY2023 pixy Disaggregation Of Revenuepolicytextblock
DisaggregationOfRevenuepolicytextblock
<p style="font-size:10pt;font-family:times new roman;margin:0px">The Company’s primary revenue streams include HCM / EAS and staffing services. The Company’s disaggregated revenues for the year ended August 31,2023 and August 31, 2022, respectively, were as follows (in millions): </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>For the Years Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Revenue (in thousands): </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">HCM / EAS (1)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:11%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.6</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:11%;vertical-align:bottom;text-align:right;">6.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Staffing</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> 15.5</p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;vertical-align:bottom;text-align:right;">29.6</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">17.1</p></td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;vertical-align:bottom;text-align:right;">36.0</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(1) HCM / EAS revenue is presented net, $39.0 gross less worksite employees payroll cost of $37.4 for the years end August 31, 2023 and August 31, 2022, $52.2 million gross less worksite employees payroll cost of $45.8, respectively. </p><p style="font-size:10pt;font-family:times new roman;margin:0px">   </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the years ended August 31, 2023, and August 31, 2022, respectively, the following states represented more than 10% of total revenues:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="6" style="BORDER-BOTTOM: 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>For the Years Ended  </strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>States:  </strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">California</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:11%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> 51.7</p></td><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:11%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">52.1</p></td><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Washington </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">11.6</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">13.3</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">New Mexico</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">10.8</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">8.1</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr></tbody></table>
CY2023 us-gaap Revenues
Revenues
17100000 usd
CY2022 us-gaap Revenues
Revenues
36000000.0 usd
CY2023 pixy Worksite Employee Payroll Cost
WorksiteEmployeePayrollCost
37400000 usd
CY2022 pixy Worksite Employee Payroll Cost
WorksiteEmployeePayrollCost
45800000 usd
CY2023Q3 pixy Public Offering Price Per Share
PublicOfferingPricePerShare
36.00
CY2023Q3 pixy Per Share Par Value
PerShareParValue
0.0001
CY2023Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
2700000 usd
CY2023Q3 pixy Expenses For Non Cash Warrant Modification
ExpensesForNonCashWarrantModification
200000 usd
CY2021Q2 us-gaap Incremental Common Shares Attributable To Accelerated Share Repurchase Agreements
IncrementalCommonSharesAttributableToAcceleratedShareRepurchaseAgreements
2062 shares
CY2023Q3 pixy Assets Held In The Trust Account
AssetsHeldInTheTrustAccount
0 usd
CY2022Q3 pixy Assets Held In The Trust Account
AssetsHeldInTheTrustAccount
117000000.0 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company maintains cash with a commercial bank, which is insured by the Federal Deposit Insurance Corporation (“FDIC”). At various times, the Company has deposits in this financial institution in excess of the amount insured by the FDIC. The Company has not experienced any losses related to these balances and believes its credit risk to be minimal. As of August 31, 2023, and August 31, 2022, there was $0.0 million and $0.6 million, respectively, of cash on deposit in excess of the amounts insured by the FDIC.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following represents clients who have ten percent of total accounts receivable as of August 31, 2023, and August 31, 2022, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>As of</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Client 1</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:10%;vertical-align:bottom;text-align:right;">64.5</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:10%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Client 2</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">23.6</td><td style="vertical-align:bottom;white-space: nowrap;">%</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">41.9</td><td style="vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Client 3</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">5.6</td><td style="vertical-align:bottom;white-space: nowrap;">%</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">13.7</td><td style="vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Client 4</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">3.3</td><td style="vertical-align:bottom;white-space: nowrap;">%</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">21.9</td><td style="vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Client 5</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.0</td><td style="vertical-align:bottom;white-space: nowrap;">%</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">20.7</td><td style="vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following represents clients who have ten percent of gross revenues for the years ended August 31, 2023, and August 31, 2022, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Client 1</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">13.9</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">7.8</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Client 2</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10.6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10.7</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table>
CY2023Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
0.0 usd
CY2022Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
600000 usd
CY2023 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
500000 usd
CY2022 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
50000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
300000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2500000 usd
CY2023 us-gaap Utilities Operating Expense Impairments
UtilitiesOperatingExpenseImpairments
3900000 usd
CY2022 us-gaap Utilities Operating Expense Impairments
UtilitiesOperatingExpenseImpairments
7900000 usd
CY2023Q2 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
400000 usd
CY2023 pixy Everest Litigation Settlement Description
EverestLitigationSettlementDescription
As a result of the settlement, the Company recorded a gain of $1.0 million during the year ended August 31, 2023. The
CY2023Q3 pixy Discontinuedoperationliabilitiesagainstsunz Program
DiscontinuedoperationliabilitiesagainstsunzProgram
5600000 usd
CY2022Q3 pixy Discontinuedoperationliabilitiesagainstsunz Program
DiscontinuedoperationliabilitiesagainstsunzProgram
5000000.0 usd
CY2023Q3 pixy Workers Compensation Asset Current
WorkersCompensationAssetCurrent
1200000 usd
CY2022Q3 pixy Workers Compensation Asset Current
WorkersCompensationAssetCurrent
600000 usd
CY2023Q3 pixy Workers Compensation Asset Noncurrent
WorkersCompensationAssetNoncurrent
0 usd
CY2022Q3 pixy Workers Compensation Asset Noncurrent
WorkersCompensationAssetNoncurrent
1200000 usd
CY2023Q3 pixy Workers Compensation Liabilities Current
WorkersCompensationLiabilitiesCurrent
4400000 usd
CY2022Q3 pixy Workers Compensation Liabilities Current
WorkersCompensationLiabilitiesCurrent
1400000 usd
CY2023Q3 pixy Workers Compensation Liabilities Noncurrent
WorkersCompensationLiabilitiesNoncurrent
0 usd
CY2022Q3 pixy Workers Compensation Liabilities Noncurrent
WorkersCompensationLiabilitiesNoncurrent
3300000 usd
CY2023 us-gaap Impairment Of Leasehold
ImpairmentOfLeasehold
1000000.0 usd
CY2023 us-gaap Advertising Expense
AdvertisingExpense
2300000 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
2600000 usd
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y10M24D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
15672.00
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
58 shares
CY2022 pixy Weighted Average Remaining Contractual Life In Years Vested
WeightedAverageRemainingContractualLifeInYearsVested
P9Y9M18D
CY2023 pixy Net Income Loss Loss From Discontinued Operations
NetIncomeLossLossFromDiscontinuedOperations
200000 usd
CY2022 pixy Net Income Loss Loss From Discontinued Operations
NetIncomeLossLossFromDiscontinuedOperations
600000 usd
CY2021Q2 pixy Description Of Class Of Warrant Modification
DescriptionOfClassOfWarrantModification
(i) amended the investor warrants to reduce their exercise price per share to $2,880.00.and (ii) provided for the issuance of a new warrant to purchase up to approximately 4,164 shares of the Company’s common stock (the “January 2022 common warrant”), with such January 2022 common warrant being issued on the basis of two January 2022 common warrant shares for each share of the existing warrant that was exercised for cash. The January 2022 common warrant is exercisable commencing on July 28, 2022, terminates on July 28, 2027, and has an exercise price per share of $3,077.00. The exercise agreement generated aggregate proceeds to the Company of approximately $5.9 million, prior to the deduction of $0.5 million of costs consisting of placement agent commissions and offering expenses payable by the Company
CY2023 pixy Scheduleofdisposalgroupsincludingdiscontinuedoperationsincome Tax Expenses Tabletextblock
ScheduleofdisposalgroupsincludingdiscontinuedoperationsincomeTaxExpensesTabletextblock
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>For the Years Ended </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Income expense tax (benefit)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">     Federal tax expense (benefit)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:11%;vertical-align:bottom;text-align:right;">47,000 </td><td style="width:1%;white-space: nowrap;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:11%;vertical-align:bottom;text-align:right;">(114,000 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">State tax expense (benefit)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">17,000</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">(45,000 </td><td style="PADDING-BOTTOM: 1px;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 24.75pt">Total tax expense (benefit)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">64,000 </td><td style="white-space: nowrap;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">(159,000 </td><td style="vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 24.75pt">Loss carryforwards</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">(64,000 </td><td style="PADDING-BOTTOM: 1px;vertical-align:bottom;white-space: nowrap;">)</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">159,000</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Income tax expense from discontinued operations</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">—</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">—</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
200000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023 pixy Unbilled Revenue
UnbilledRevenue
1800000 usd
CY2022 pixy Unbilled Revenue
UnbilledRevenue
2100000 usd
CY2023Q3 pixy Liability Against Accounts Receivable
LiabilityAgainstAccountsReceivable
200000 usd
CY2022Q3 pixy Liability Against Accounts Receivable
LiabilityAgainstAccountsReceivable
0 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3400000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4024000 usd
CY2023Q3 pixy Accumulated Depreciation Amortization
AccumulatedDepreciationAmortization
-1778000 usd
CY2023Q3 us-gaap Assets Net
AssetsNet
1622000 usd
CY2023 us-gaap Depreciation
Depreciation
500000 usd
CY2022 us-gaap Depreciation
Depreciation
500000 usd
CY2023 pixy Impairment Expense
ImpairmentExpense
1000000.0 usd
CY2022 pixy Impairment Expense
ImpairmentExpense
0 usd
CY2021Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
49485 shares
CY2022Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
29062000 shares
CY2022Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
50000000000 shares
CY2023 pixy Accrued Payroll And Related Liabilitiesdisclosuretextblock
AccruedPayrollAndRelatedLiabilitiesdisclosuretextblock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 8: Payroll Tax And Related Liabilities</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accrued payroll liabilities consisted of the following as of August 31, 2023, and August 31, 2022:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>August 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Payroll taxes liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:11%;vertical-align:bottom;text-align:right;">22,840,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:11%;vertical-align:bottom;text-align:right;">12,932,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Payroll related liabilities </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">237,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">346,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued penalties and interest</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">6,518,000</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:right;">897,000</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">29,595,000</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;vertical-align:bottom;text-align:right;">14,175,000</td><td style="PADDING-BOTTOM: 3px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">    </p><p style="font-size:10pt;font-family:times new roman;margin:0px">Payroll tax liabilities and payroll tax accrual are associated with the Company’s WSEs as well as its corporate employees. The Company has recorded approximately $6.5 million and $0.9 million in interest and penalties on approximately $22.8 million and $12.9 million on delinquent outstanding payroll taxes to the IRS and states and local authorities. In addition, the has received notices from the IRS has for approximately $11.8 million for unpaid tax liabilities including penalties and interest. The IRS can levy the Company’s bank accounts and is subject to enforcement collections. ShiftPixy has requested for a collection due process or equivalent hearing, that are subject to enforced collection.  ShiftPixy has also filed for an abatement of additions to tax and related interest for the failure to make required deposits and the failure to timely pay required tax that are subject to enforced collection.  That request is pending before the IRS Independent Office of Appeals.</p>
CY2023Q3 pixy Payroll Taxes Liabilities
PayrollTaxesLiabilities
22840000 usd
CY2022Q3 pixy Payroll Taxes Liabilities
PayrollTaxesLiabilities
12932000 usd
CY2023Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
237000 usd
CY2022Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
346000 usd
CY2023Q3 pixy Income Tax Penalties And Interest Accrued
IncomeTaxPenaltiesAndInterestAccrued
6518000 usd
CY2022Q3 pixy Income Tax Penalties And Interest Accrued
IncomeTaxPenaltiesAndInterestAccrued
897000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
29595000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14175000 usd
CY2023Q3 pixy Accrued Interest And Penalties On Payroll Taxes Current
AccruedInterestAndPenaltiesOnPayrollTaxesCurrent
6500000 usd
CY2022Q3 pixy Accrued Interest And Penalties On Payroll Taxes Current
AccruedInterestAndPenaltiesOnPayrollTaxesCurrent
900000 usd
CY2023Q3 pixy Elinquent Payroll Taxes Outstanding
elinquentPayrollTaxesOutstanding
22800000 usd
CY2022Q3 pixy Elinquent Payroll Taxes Outstanding
elinquentPayrollTaxesOutstanding
12900000 usd
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
358333 shares
CY2022Q3 pixy Stock Issued During Period Shares Stock Options Exercised Shares
StockIssuedDuringPeriodSharesStockOptionsExercisedShares
4400000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.037 pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.494 pure
CY2022Q1 srt Federal Funds Sold Average Yield
FederalFundsSoldAverageYield
0 pure
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P6Y8M12D
CY2022Q1 pixy Sharebased Compensation Arrangement By Sharebased Payment Award Expiration
SharebasedCompensationArrangementBySharebasedPaymentAwardExpiration
P6Y9M18D
CY2022Q3 pixy Sale Of Stock Placement Fee
SaleOfStockPlacementFee
0.070 pure
CY2023Q1 pixy Form S3 Registration Statement Filed
FormS3RegistrationStatementFiled
100000000 usd
CY2023Q1 pixy Sale Of Equity Securities
SaleOfEquitySecurities
100000000 usd
CY2023 us-gaap Marketing Expense
MarketingExpense
8200000 usd
CY2022 pixy Proceeds From Sale Of Stock
ProceedsFromSaleOfStock
1900000 usd
CY2023 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
18305 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48612 shares
CY2023Q3 pixy Pre Funded Warrants Issued
PreFundedWarrantsIssued
37500 shares
CY2023Q3 pixy Common Warrants Shares Issued
CommonWarrantsSharesIssued
86112 shares
CY2021Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4006 shares
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M24D
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
9216
CY2022 pixy Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
23880 shares
CY2022 pixy Class Of Warrant Or Right Weighted Average Remaining Life Issued
ClassOfWarrantOrRightWeightedAverageRemainingLifeIssued
P7Y7M6D
CY2022 pixy Class Of Warrant Or Right Weighted Average Exercise Price Issued
ClassOfWarrantOrRightWeightedAverageExercisePriceIssued
1992
CY2022 pixy Class Of Warrant Or Right Cancelled
ClassOfWarrantOrRightCancelled
-1 shares
CY2022 pixy Class Of Warrant Or Right Weighted Average Exercise Price Cancelled
ClassOfWarrantOrRightWeightedAverageExercisePriceCancelled
662400
CY2022 pixy Class Of Warrant Or Right Shares Exercised
ClassOfWarrantOrRightSharesExercised
6102 shares
CY2022 pixy Class Of Warrant Or Right Weighted Average Remaining Life Exercised
ClassOfWarrantOrRightWeightedAverageRemainingLifeExercised
P5Y2M12D
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
21783 shares
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M12D
CY2022Q3 pixy Weighted Average Exercise Price Exercisable
WeightedAverageExercisePriceExercisable
1139.76
CY2023 pixy Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
159201 shares
CY2023 pixy Class Of Warrant Or Right Weighted Average Remaining Life Issued
ClassOfWarrantOrRightWeightedAverageRemainingLifeIssued
P5Y4M24D
CY2023 pixy Class Of Warrant Or Right Weighted Average Exercise Price Issued
ClassOfWarrantOrRightWeightedAverageExercisePriceIssued
29.05
CY2023 pixy Class Of Warrant Or Right Cancelled
ClassOfWarrantOrRightCancelled
-5175 shares
CY2023 pixy Class Of Warrant Or Right Weighted Average Exercise Price Cancelled
ClassOfWarrantOrRightWeightedAverageExercisePriceCancelled
3741.94
CY2023 pixy Class Of Warrant Or Right Shares Exercised
ClassOfWarrantOrRightSharesExercised
37500 shares
CY2023Q3 pixy Class Of Warrant Or Right Shares Exercisable
ClassOfWarrantOrRightSharesExercisable
138309 shares
CY2023 pixy Weighted Remaining Life Years Exercisable
WeightedRemainingLifeYearsExercisable
P5Y7M6D
CY2023Q3 pixy Weighted Average Exercise Price Exercisable
WeightedAverageExercisePriceExercisable
208.78
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
138309 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P9Y7M6D
CY2023Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
208.78
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
30833 shares
CY2023 pixy Stock Based Compensation Expenses
StockBasedCompensationExpenses
1000000.0 usd
CY2022 pixy Stock Based Compensation Expenses
StockBasedCompensationExpenses
1300000 usd
CY2023 us-gaap Officers Compensation
OfficersCompensation
3100000 usd
CY2023Q3 pixy Accounts Payable And Others Accrued Liabilities
AccountsPayableAndOthersAccruedLiabilities
200000 usd
CY2022Q3 pixy Accounts Payable And Others Accrued Liabilities
AccountsPayableAndOthersAccruedLiabilities
200000 usd
CY2023Q3 us-gaap Accrued Rent Current
AccruedRentCurrent
700000 usd
CY2022Q3 us-gaap Accrued Rent Current
AccruedRentCurrent
600000 usd
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
740 shares
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
2520.00
CY2022 pixy Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedNumberOfShares
0 shares
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
30900000 shares
CY2022 pixy Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageRemainingContractualTerm
P8Y4M24D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
10896.00
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
490 shares
CY2022 pixy Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Weighted Average Remaining Contractual Term C6
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageRemainingContractualTermC6
P8Y1M6D
CY2022Q3 pixy Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstandings Weighted Average Exercise Price F
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingsWeightedAverageExercisePriceF
17592.00
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
0 shares
CY2023 pixy Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedNumberOfShares
0 shares
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
73 shares
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
454.00
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
417 shares
CY2023 pixy Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Weighted Average Remaining Contractual Term C6
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageRemainingContractualTermC6
P7Y
CY2023Q3 pixy Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstandings Weighted Average Exercise Price F
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingsWeightedAverageExercisePriceF
19528.80
CY2023 pixy Share Based Compensation Arrangement By Share Based Payment Award Options Exercisables Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablesWeightedAverageExercisePrice
315
CY2023 pixy Weighted Average Remaining Contractual Life In Years Exercisable
WeightedAverageRemainingContractualLifeInYearsExercisable
P7Y1M6D
CY2023 pixy Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Exercisable Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageExercisableDateFairValue
21483.64
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
800000 usd
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y10M24D
CY2023Q3 pixy Number Of Options Outstanding Outstanding In Shares
NumberOfOptionsOutstandingOutstandingInShares
417 shares
CY2023Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
315 shares
CY2023 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7M
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
19528.80
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
315 shares
CY2023 pixy Share Based Payment Arrangement Option Exercise Price Range Vested Weighted Average Remaining Contractual Term
ShareBasedPaymentArrangementOptionExercisePriceRangeVestedWeightedAverageRemainingContractualTerm
P7Y1M6D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
21483.64
CY2023 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
28000 usd
CY2022 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
38000 usd
CY2023 us-gaap Legal Fees
LegalFees
500000 usd
CY2022 us-gaap Legal Fees
LegalFees
1000000.0 usd
CY2022Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
31224000 usd
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
347000 usd
CY2022Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
587000 usd
CY2023Q3 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Financing Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
347000 usd
CY2022Q3 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Financing Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
587000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6500000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
8566000 usd
CY2023Q3 pixy Contingent Lease Liability Current
ContingentLeaseLiabilityCurrent
3761000 usd
CY2022Q3 pixy Contingent Lease Liability Current
ContingentLeaseLiabilityCurrent
3761000 usd
CY2023Q3 pixy Right Of Use Liability Current
RightOfUseLiabilityCurrent
900000 usd
CY2022Q3 pixy Right Of Use Liability Current
RightOfUseLiabilityCurrent
754000 usd
CY2023Q3 pixy Legal Settlement Against Accounts Payable And Accrued Liabilities
LegalSettlementAgainstAccountsPayableAndAccruedLiabilities
1660000 usd
CY2022Q3 pixy Legal Settlement Against Accounts Payable And Accrued Liabilities
LegalSettlementAgainstAccountsPayableAndAccruedLiabilities
0 usd
CY2023Q3 pixy Shares Owed To Directors For Servicesagainstaccountspayableandaccruedliabilities
SharesOwedToDirectorsForServicesagainstaccountspayableandaccruedliabilities
800000 usd
CY2022Q3 pixy Shares Owed To Directors For Servicesagainstaccountspayableandaccruedliabilities
SharesOwedToDirectorsForServicesagainstaccountspayableandaccruedliabilities
606000 usd
CY2023Q3 pixy Ertc Owed To Clientsagainstaccountspayableandaccruedliablities
ErtcOwedToClientsagainstaccountspayableandaccruedliablities
1089000 usd
CY2022Q3 pixy Ertc Owed To Clientsagainstaccountspayableandaccruedliablities
ErtcOwedToClientsagainstaccountspayableandaccruedliablities
417000 usd
CY2023Q3 pixy Financed Insurance Policiesagainstaccountspayableandaccruedliabilities
FinancedInsurancePoliciesagainstaccountspayableandaccruedliabilities
457000 usd
CY2022Q3 pixy Financed Insurance Policiesagainstaccountspayableandaccruedliabilities
FinancedInsurancePoliciesagainstaccountspayableandaccruedliabilities
0 usd
CY2023Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
1525000 usd
CY2022Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
2121000 usd
CY2023Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
16692000 usd
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
16225000 usd
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
30936000 usd
CY2022Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
26069000 usd
CY2023Q3 pixy Businessinterest
Businessinterest
3349000 usd
CY2022Q3 pixy Businessinterest
Businessinterest
2942000 usd
CY2023Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
1347000 usd
CY2022Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
896000 usd
CY2023Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
1487000 usd
CY2022Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
1734000 usd
CY2023Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
60000 usd
CY2022Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
135000 usd
CY2023Q3 pixy Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
742000 usd
CY2022Q3 pixy Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
31000 usd
CY2023Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1000 usd
CY2022Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
4000 usd
CY2023Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
37922000 usd
CY2022Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
31811000 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
37575000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
347000 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
587000 usd
CY2023Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
13000 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-38000 usd
CY2023 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
13000 usd
CY2022 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
-38000 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-4774000 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-6177000 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1715000 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-2476000 usd
CY2023 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-6489000 usd
CY2022 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-8653000 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
6489000 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
8653000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-38000 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7164000 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-9124000 usd
CY2023 pixy Effective Income Tax Rate Reconciliation Inducement Loss Amount
EffectiveIncomeTaxRateReconciliationInducementLossAmount
68000 usd
CY2022 pixy Effective Income Tax Rate Reconciliation Inducement Loss Amount
EffectiveIncomeTaxRateReconciliationInducementLossAmount
917000 usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
1813000 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
1227000 usd
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1420000 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1983000 usd
CY2023 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-227000 usd
CY2022 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
272000 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6489000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
8653000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-38000 usd
CY2023Q3 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
6500000 usd
CY2022Q3 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
8700000 usd
CY2023Q3 pixy Net Operating Losses
NetOperatingLosses
101200000 usd
CY2022 pixy Operating Leases Impairment Loss
OperatingLeasesImpairmentLoss
380000 usd
CY2023Q3 pixy Contingent Liability
ContingentLiability
3800000 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
1081000 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
1363000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1056000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1090000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
823000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
643000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
378000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
130000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4120000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
455000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3655000 usd
CY2022 pixy Weighted Average Remaining Lease Term Operating Leasesterm
WeightedAverageRemainingLeaseTermOperatingLeasesterm
P58Y
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0554 pure
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3900000 usd
CY2023 pixy Received Employee Retention Tax Credit Amount
ReceivedEmployeeRetentionTaxCreditAmount
1200000 usd
CY2023 pixy Total Received Employee Retention Tax Credit Amount
TotalReceivedEmployeeRetentionTaxCreditAmount
4100000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3500000 usd
CY2022Q4 pixy Settlement Amount
SettlementAmount
550000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
550000 usd

Files In Submission

Name View Source Status
0001477932-23-009152-index-headers.html Edgar Link pending
0001477932-23-009152-index.html Edgar Link pending
0001477932-23-009152.txt Edgar Link pending
0001477932-23-009152-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pixy-20230831.xsd Edgar Link pending
pixy_10k.htm Edgar Link pending
pixy_10kimg11.jpg Edgar Link pending
pixy_10kimg12.jpg Edgar Link pending
pixy_10kimg13.jpg Edgar Link pending
pixy_10kimg14.jpg Edgar Link pending
pixy_10kimg15.jpg Edgar Link pending
pixy_10kimg16.jpg Edgar Link pending
pixy_10kimg17.jpg Edgar Link pending
pixy_10kimg18.jpg Edgar Link pending
pixy_10kimg19.jpg Edgar Link pending
pixy_10kimg20.jpg Edgar Link pending
pixy_ex211.htm Edgar Link pending
pixy_ex231.htm Edgar Link pending
pixy_ex311.htm Edgar Link pending
pixy_ex312.htm Edgar Link pending
pixy_ex321.htm Edgar Link pending
pixy_ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
pixy-20230831_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
pixy-20230831_lab.xml Edgar Link unprocessable
pixy-20230831_def.xml Edgar Link unprocessable
pixy-20230831_cal.xml Edgar Link unprocessable
pixy_10k_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending